BioCentury
ARTICLE | Clinical News

CLPA starts Crohn's Phase II

July 22, 2002 7:00 AM UTC

Cell Pathways (CLPA) began an open-label Phase II trial of its oral CP461 in 30 patients with moderate to severely active Crohn's disease. The primary endpoint of the eight-week trial will be a clinic...